OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at firstname.lastname@example.org
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
How Gilead readied remdesivir for the COVID challenge.
How the UK is making progress in this hi-tech field.
Looking Back at 1997–1999.
Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.
With COVID-19 severely disrupting the care of cancer patients in the UK, Astellas’ Jackie Williams talks about how UK pharma can partner with the NHS to address patient backlogs and support continuity of care.
Rosanne Rotondo talks to Pharm Exec about recent breakthroughs in the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis and the work of Novartis’ other Global Health Flagship Programs.
A coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction.
Recruitment of data scientists is much more than a numbers game.
Pratap Khedkar, managing principal for ZS’ global pharmaceuticals practice, talks to Pharm Exec about what companies need to focus on to achieve and optimize digital transformation in 2021 and beyond.